Misplaced Pages

Meralgia paresthetica
Other names	Bernhardt-Roth syndrome
Innervation of lateral cutaneous nerve of the thigh (shaded area) on the right leg.
Specialty	Neurology
Symptoms	Pain, dysthesias, paresthesias, and hyperesthesia on the anterolateral thigh
Causes	Anything that compresses the lateral femoral cutaneous nerve, such as tight fitting clothes at the waist and injuries.
Risk factors	Obesity, pregnancy, diabetes, middle-age
Diagnostic method	Clinical examination and patient history
Differential diagnosis	Lumbar L2/L3 pathology, lumbar plexopathy, another entrapped peripheral nerve, and pelvic tumors
Treatment	Steroid injections, nerve decompression, and neurectomy

Meralgia paresthetica or meralgia paraesthetica is pain or abnormal sensations in the outer thigh not caused by injury to the thigh, but by injury to a nerve which provides sensation to the lateral thigh.

Meralgia paresthetica is a specific instance of nerve entrapment. The nerve involved is the lateral femoral cutaneous nerve (LFCN). The symptoms are purely sensory because the LFCN has no motor function. This syndrome can be caused by anything which places prolonged pressure on the LFCN, such as wearing a tight belt. The diagnosis is typically done via clinical examination and patient history, followed by a diagnostic nerve block. The condition will often resolve on its own within two years even without treatment. Non-surgical treatments include lifestyle changes, physical therapy, and therapeutic injections. Surgical treatments include nerve decompression and neurectomy.

Anatomy

The lateral femoral cutaneous nerve (LFCN) originates from the lumbar plexus and contains fibers from lumbar nerves L2 and L3. The LFCN then traverses to the lateral border of the psoas major muscle, crosses the iliacus muscle, and continues to the anterior superior iliac spine (bony landmark). The nerve then passes between inguinal ligament (passes under) and sartorius muscle (passes over). It then divides into an anterior and posterior branch as it travels into the thigh.

Signs and symptoms

The lateral femoral cutaneous nerve (LFCN) is a purely sensory nerve, and consequently the symptoms are also sensory. Symptoms are typically unilateral, seen in about 78% of cases, but may be bilateral.

The most common symptom is pain, paresthesias, or dysthesias on the anterolateral surface of the thigh that extends just above the knee. (The term "meralgia paraesthetica" combines four Greek roots to mean "thigh pain with abnormal sensations".) Examples of paresthesias (abnormal sensations but not unpleasant) and dysthesias (abnormal sensations that are unpleasant) are burning, tingling, numbness, stinging, hypersensitivity, and itching. The symptom intensity can be mild to severe in a way that limits function due to pain.

Activity and position can affect the symptoms. For example, symptoms may be exacerbated by standing or prolonged hip extension, with relief when sitting or flexing the hip. Sometimes strenuous exercise may exacerbate symptoms.

Causes

The cause of Meralgia Paresthetica (MP) is nerve compression or injury to the lateral femoral cutaneous nerve (LFCN).

The site of compression is often at or near the inguinal ligament as the LFCN passes between the upper front hip bone (ilium) and the inguinal ligament near the attachment at the anterior superior iliac spine (the upper point of the hip bone).

Causes of compression can be due to tight fitting clothing at the waist, tight belts, or tight seat belts placing pressure on the LFCN. It can also be due to conditions which increase intra-abdominal volume and consequently pressure on the LFCN such as ascites, obesity, and pregnancy. Less commonly, anything that directly presses on the LFCN anywhere along its course, such a tumor or cyst, can also be a cause. Meralgia Paresthetica can also be caused by accidents that cause injury to the LFCN such as a seat belt injury from a car accident. Iatrogenic injuries to the LFCN are also possible and can happen due to peri-operative positioning or spinal, pelvic, and abdominal operations. In cases where MP is elicited by strenuous physical activity, it's thought that anatomic variations may predispose the LFCN to compression with certain limb movements.

Pathophysiology

Anatomic variations in the course of the lateral femoral cutaneous nerve (LFCN) through the inguinal ligament, its branching level, and course through the thigh is thought to predispose the LFCN to nerve damage through injury or nerve compression.

Diagnosis

Diagnosis is generally based on clinical examination and patient history. The clinical examination may include checking the region that the patient is reporting paresthetias/dysthesias as well as sensory differences between each leg if the symptoms are unilateral. Patient history might include relevant details about recent surgeries, injuries, lifestyle activities that could irritate the nerve.

In typical cases a nerve block is performed. In a nerve block, an anesthetic injection near the nerve numbs the entire nerve to confirm lateral femoral cutaneous nerve (LFCN) involvement and also to distinguish it from lumbosacral root pain. The nerve block test of the LFCN is considered positive if the patient has immediate symptom relief lasting 30–40 minutes after the injection.

Atypical presentations involve an extended workup that involves imaging, electrophysiology testing, neurosonography to rule out similar conditions with overlapping symptoms (differential diagnoses). Some differential diagnoses include L2/L3 lumbar radiculopathy, another entrapped peripheral nerve (e.g. femoral neuropathy), lumbar plexopathy, abdominal masses, and pelvic tumors.

A lumbar MRI can rule out lumbar radiculopathy. Imaging like MRI/CT/x-ray can be used to rule out mass lesions (e.g. tumors) that could compress the LFCN. Magnetic resonance neurography (MRN) can be used to assess signal alterations along the LFCN. Neurophysiological testing can include sensory nerve conduction studies or somatosensory evoked potentials. Image-guided nerve blocks can be used to rule out the involvement of other nerves.

Treatment

Meralgia Paresthetica is typically a self-limiting condition with spontaneous remission. In one study evaluating the natural history of Meralgia Paresthetica, 62% of patients with no treatment had complete symptom resolution after 2 years. The limitation in existing treatment data is that there are no randomized control trials, much of the data is observational, and it is difficult to distinguish the effectiveness of a treatment from the natural history of the disease (how the disease progresses without treatment).

Conservative

Conservative therapy seeks to reduce aggravating factors. This includes eliminating tight fitting clothing and tight belts, losing weight, avoiding activities that aggravate symptoms, and physical therapy to stretch the muscles and tendons present along the course of the lateral femoral cutaneous nerve.

Medications can be used for symptomatic treatment. Examples include NSAIDs, topical capsaicin, and lidocaine gel/patches for epidermal hypersensitivity or dysesthesia.

Nerve blocks can also be used therapeutically especially if combined with corticosteroids. The relief from steroid injections is highly variable, with long-term, complete pain relief of approximately 22%. The revision rate for injections is approximately 81% and a revision is likely to either be a repeat injection or a nerve decompression.

An emerging non-surgical treatment is radiofrequency ablation to destroy the lateral femoral cutaneous nerve.

Surgical

If repeated nerve blocks don't lead to symptom improvement, then surgery is recommended.

The main surgical treatments for Meralgia Paresthetica are nerve decompression and neurectomy. The main difference between the decompression and neurectomy is that the decompression will remove material around the nerve which might compress it, while the neurectomy removes the nerve itself. By keeping the nerve intact, a decompression preserves sensation. With a neuroectomy, there will be permanent numbness distal to the site of transaction because the nerve is transected and removed. However, in studies measuring patient quality of life, patients seem to be rarely bothered by the loss of sensation.

While both procedures are effective, the neurectomy has better outcomes on complete pain relief. In a systematic review, complete pain relief was seen in 85% of neurectomy cases and 63% of decompression cases. A Cochrane review found that complete pain relief in 85-100% of neurectomy cases and 60-99% of decompression cases. The revision rate for nerve decompression is 12% and a revision was either a repeat decompression or neurectomy. The revision rate for neurectomy is approximately 0%.

One systematic review found that the complication rate after neurectomy is 0%, and after neurolysis is 5%. The most common complications after either surgery is hematomas, subcutaneous effusions, wound healing disorders, and wound infections.

Epidemiology

The incidence is 32-43 cases per 100,000 people per year. There is an association between Meralgia Paresthetica (MP) and age, body mass index (BMI), and diabetes. In 68% of cases MP occurs in middle-aged men.

History

Meralgia Paresthetica (MP) was first described in 1885 by Martin Bernhardt and named by Vladimir Karlovich Roth in 1895. Roth noticed the syndrome in cavalrymen who wore their belts too tightly. Consequently, Meralgia Paresthetica is also known as Bernhardt-Roth syndrome.

Society and culture

The disorder has also been nicknamed bikini brief syndrome and skinny pants syndrome, because it can be caused by wearing tight clothing.

See also

• lateral femoral cutaneous nerve
• medical concerns due to low rise jeans
• nerve compression syndrome
• neurectomy
• paresthesia
• dysesthesia
• hyperalgesia

References

1. Pearce JM (2006). "Meralgia paraesthetica (Bernhardt-Roth syndrome)". Journal of Neurology, Neurosurgery & Psychiatry. 77 (1): 84. doi:10.1136/jnnp.2005.072363. PMC 2117390. PMID 16361600.
2. ^ Khalil N, Nicotra A, Rakowicz W (December 2012). "Treatment for meralgia paraesthetica". Cochrane Database Syst Rev. 12 (12): CD004159. doi:10.1002/14651858.CD004159.pub3. PMC 7197425. PMID 23235604.
3. ^ Scholz C, Hohenhaus M, Pedro MT, Uerschels AK, Dengler NF (September 2023). "Meralgia Paresthetica: Relevance, Diagnosis, and Treatment". Dtsch Arztebl Int. 120 (39): 655–661. doi:10.3238/arztebl.m2023.0170. PMC 10622057. PMID 37534445.
4. ^ Coffey R, Gupta V. Meralgia Paresthetica. . In: StatPearls . Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557735/
5. ^ Cheatham SW, Kolber MJ, Salamh PA (December 2013). "Meralgia paresthetica: a review of the literature". Int J Sports Phys Ther. 8 (6): 883–93. PMC 3867081. PMID 24377074.
6. ^ Schönberg B, Pigorsch M, Huscher D, Baruchi S, Reinsch J, Zdunczyk A, Scholz C, Uerschels AK, Dengler NF (February 2023). "Diagnosis and treatment of meralgia paresthetica between 2005 and 2018: a national cohort study". Neurosurg Rev. 46 (1): 54. doi:10.1007/s10143-023-01962-0. PMC 9925535. PMID 36781569.
7. ^ de Ruiter GC, Oosterhuis JW, Vissers TF, Kloet A (May 2023). "Unusual causes for meralgia paresthetica: systematic review of the literature and single center experience". Neurosurg Rev. 46 (1): 107. doi:10.1007/s10143-023-02023-2. PMC 10162905. PMID 37148363.
8. ^ Lu VM, Burks SS, Heath RN, Wolde T, Spinner RJ, Levi AD (January 2021). "Meralgia paresthetica treated by injection, decompression, and neurectomy: a systematic review and meta-analysis of pain and operative outcomes". J Neurosurg. 135 (3): 912–922. doi:10.3171/2020.7.JNS202191. PMID 33450741.
9. ^ ECKER AD, WOLTMAN HW. MERALGIA PARAESTHETICA: A REPORT OF ONE HUNDRED AND FIFTY CASES. JAMA. 1938;110(20):1650–1652. doi:10.1001/jama.1938.02790200018006
10. Ivins GK (2000). "Meralgia Paresthetica, the Elusive Diagnosis". Annals of Surgery. 232 (2): 281–6. doi:10.1097/00000658-200008000-00019. PMC 1421141. PMID 10903608.
11. Kho KH, Blijham PJ, Zwarts MJ (June 2005). "Meralgia paresthetica after strenuous exercise". Muscle Nerve. 31 (6): 761–3. doi:10.1002/mus.20271. PMID 15654691.
12. Chhabra A, Del Grande F, Soldatos T, Chalian M, Belzberg AJ, Williams EH, Jalali FS, Thawait GK, Eng J, Carrino JA (June 2013). "Meralgia paresthetica: 3-Tesla magnetic resonance neurography". Skeletal Radiol. 42 (6): 803–8. doi:10.1007/s00256-012-1557-4. PMID 23306718.
13. van Slobbe AM, Bohnen AM, Bernsen RM, Koes BW, Bierma-Zeinstra SM (March 2004). "Incidence rates and determinants in meralgia paresthetica in general practice". J Neurol. 251 (3): 294–7. doi:10.1007/s00415-004-0310-x. PMID 15015008.
14. Pearce JM (January 2006). "Meralgia paraesthetica (Bernhardt-Roth syndrome)". J Neurol Neurosurg Psychiatry. 77 (1): 84. doi:10.1136/jnnp.2005.072363. PMC 2117390. PMID 16361600.
15. Lambert HW, Wineski LE (July 2010). Lippincott's Illustrated Q&A Review of Anatomy and Embryology. Lippincott Williams & Wilkins. ISBN 978-1-60547-315-4.
16. "Make your pencil jeans less dangerous to your health". Vanguard. March 8, 2012.

External links

• Meralgia Paresthetica at eMedicine.com

• Neurological disorders
• Neurocutaneous conditions